Research graph
References from Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma
10.1200/jco.2005.04.6136 · 2006 · External reference
Human papillomavirus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers
10.1097/00001622-200105000-00009 · 2001 · External reference
Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival
10.1002/1097-0215(20000520)89:3<300::aid-ijc14>3.0.co;2-g · 2000 · External reference
Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma
10.1002/1097-0142(20010815)92:4<805::aid-cncr1386>3.0.co;2-9 · 2001 · External reference
p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma
10.1200/jco.2013.54.5228 · 2014 · External reference
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: An Italian validation study
10.1093/annonc/mdr544 · 2012 · External reference
Bayesian decision sequential analysis with survival endpoint in phase II clinical trials
10.1002/sim.3544 · 2009 · External reference
Overview of advances in head and neck cancer
10.1200/jco.2015.63.6761 · 2015 · External reference
Induction chemotherapy and sequential concomitant chemo-radiation in locally advanced head and neck cancers: How induction-phase intensity and treatment breaks may impact on clinical outcomes
2015 · External reference
Oral cavity carcinoma: Current management, controversies, and future directions
10.1200/jco.2015.61.2929 · 2015 · External reference
Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: Evolution of the sequential treatment approach
10.1053/j.seminoncol.2004.09.007 · 2004 · External reference
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer
10.1200/jco.2004.00.1990 · 2005 · External reference
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
10.1093/annonc/mdf172 · 2002 · External reference
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: Results from a single institution
10.1200/jco.1991.9.8.1376 · 1991 · External reference
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer
10.1200/jco.2003.06.006 · 2003 · External reference
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: A Southwest Oncology Group Trial
10.1200/jco.2005.04.017 · 2005 · External reference
Induction chemotherapy and radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group
10.1056/nejm199106133242402 · 1991 · External reference
Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group
10.1093/jnci/88.13.890 · 1996 · External reference
Induction chemotherapy followed by concurrent chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease
10.1200/jco.1995.13.4.876 · 1995 · External reference
Primary chemotherapy in resectable oral cavity squamous cell carcinoma: A randomized controlled trial
10.1200/jco.2003.06.146 · 2003 · External reference
Unresolved reference
External reference
Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: A University of Pennsylvania Phase II Trial
10.1200/jco.2002.11.026 · 2002 · External reference
Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 and 1999
10.1002/1097-0142(20010301)91:5<940::aid-cncr1083>3.0.co;2-a · 2001 · External reference
Low-dose fractionated radiation with induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck: 5 year results of a prospective phase II trial
10.1007/s13566-012-0074-3 · 2013 · External reference
Low-dose fractionated radiation with induction chemotherapy for locally advanced head and neck cancer: 5 year results of a prospective phase II trial
10.1016/j.ijrobp.2011.06.1026 · 2012 · External reference
Low dose hypersensitivity: Current status and possible mechanisms
10.1016/s0360-3016(00)01471-1 · 2001 · External reference
Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low-dose hypersensitivity and increased radioresistance
10.1080/09553000210166606 · 2002 · External reference
Low-dose fractionated radiation potentiates the effects of paclitaxel in wild-type and mutant p53 head and neck tumor cell lines
2003 · External reference
Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: Results of a new treatment paradigm
10.1016/j.ijrobp.2003.09.019 · 2004 · External reference
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
10.1093/jnci/92.3.205 · 2000 · External reference
Unresolved reference
External reference
p16INK4a status and response to induction low-dose fractionated radiation in advanced head and neck cancer
10.1177/0003489415579220 · 2015 · External reference
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
10.1093/jnci/djn011 · 2008 · External reference
Unresolved reference
External reference
High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck
10.1200/jco.2001.19.14.3333 · 2001 · External reference
Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells
10.1158/1535-7163.mct-10-0630 · 2011 · External reference
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial
10.1016/s1470-2045(13)70011-1 · 2013 · External reference
Biomarkers of radiation exposure: Can they predict normal tissue radiosensitivity?
10.1016/j.clon.2013.06.010 · 2013 · External reference
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: An individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group
10.1200/jco.2012.47.7802 · 2013 · External reference
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
10.1056/nejmoa070956 · 2007 · External reference
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer
2003 · External reference
